These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5623403)

  • 41. Phenobarbital-associated bone marrow aplasia: a case report and review of the literature.
    Focosi D; Kast RE; Benedetti E; Papineschi F; Galimberti S; Petrini M
    Acta Haematol; 2008; 119(1):18-21. PubMed ID: 18230962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Chronic extemporal aregenerative anemia as a possible transition form between primary global bone-marrow aplasia and chronic idiopathic erythroblastopenia not associated with thymoma. Clinical contribution].
    Gualdi CN
    Minerva Med; 1977 Mar; 68(16):1057-60. PubMed ID: 854221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First report of a B cell lymphoproliferative disorder arising in a patient treated with immune suppressants for severe aplastic anemia.
    Dorr V; Doolittle G; Woodroof J
    Am J Hematol; 1996 Jun; 52(2):108-13. PubMed ID: 8638630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic lymphocytic leukemia presenting in association with aplastic anemia.
    Zonder JA; Keating M; Schiffer CA
    Am J Hematol; 2002 Dec; 71(4):323-7. PubMed ID: 12447965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [62-year-old patient with chronic lymphatic leukaemia and persistent fever in chemotherapy induced bone marrow aplasia. Angioinvasive aspergillosis].
    Michels G; Bovenschulte H; Cornely OA; Kochanek M
    Dtsch Med Wochenschr; 2011 Jul; 136(28-29):1477-8. PubMed ID: 21567356
    [No Abstract]   [Full Text] [Related]  

  • 46. Selective erythroid and magakaryocytic aplasia after sulfasalazine administration.
    Davies GE; Palek J
    Arch Intern Med; 1980 Aug; 140(8):1122. PubMed ID: 6104949
    [No Abstract]   [Full Text] [Related]  

  • 47. [Chloramphenicol induced panmyelophthisis].
    Tulzer W
    Wien Med Wochenschr; 1972 Jun; 122(25):400-2. PubMed ID: 4114661
    [No Abstract]   [Full Text] [Related]  

  • 48. [Reticulo-endothelial nature of last surviving cells in severe bone marrow aplasia (experimental research)].
    Castaldi G; Zavagli G
    Haematologica; 1971; 56(7):249-64. PubMed ID: 5004568
    [No Abstract]   [Full Text] [Related]  

  • 49. Agranulocytosis and bone marrow aplasia induced by second-line drugs for rheumatoid arthritis. Treatment with granulocyte colony-stimulating factor.
    Sayag-Boukris V; Ziza JM; Brice P; Wechsler B
    Rev Rhum Engl Ed; 1997 Jan; 64(1):66. PubMed ID: 9051866
    [No Abstract]   [Full Text] [Related]  

  • 50. Immunosuppression as initial treatment for gold induced aplastic anemia.
    Mant MJ; Russell AS; Percy JS; Davis P; Messner HA
    J Rheumatol; 1987 Oct; 14(5):1026-9. PubMed ID: 3123673
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ["Highly polymerized" DNA in the treatment of bone marrow aplasia after radiotherapy or chemotherapy].
    Proux C; Toubiana CG
    Sem Ther; 1967 Nov; 43(9):552-3. PubMed ID: 5623403
    [No Abstract]   [Full Text] [Related]  

  • 52. [Protective effect of highly polymerized deoxyribonucleic acid against bone marrow aplasia following intense anti-cancer chemotherapy or radiocobalt irradiation].
    Wicart L; Vendrely C
    C R Acad Hebd Seances Acad Sci D; 1967 Feb; 264(6):857-60. PubMed ID: 4989170
    [No Abstract]   [Full Text] [Related]  

  • 53. Amifostine protects bone marrow from benzene-induced hematotoxicity in mice.
    Yu K; Yang KY; Ren XZ; Chen Y; Liu XH
    Int J Toxicol; 2007; 26(4):315-23. PubMed ID: 17661222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Methimazole-induced aplastic anemia].
    Mechelli S; Bolognesi S; Siuti E; Stefanelli A; Castiglioni MG
    Recenti Prog Med; 1999 Sep; 90(9):470-2. PubMed ID: 10544668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of acquired severe aplastic anemia.
    Katsanis E; Ramsay NK
    Am J Pediatr Hematol Oncol; 1989; 11(3):360-7. PubMed ID: 2675662
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.